TLDR
- Axon announced a $1.0 billion offering of 0% interest convertible senior notes due 2031
- Underwriters have an option to purchase an additional $150 million in notes
- Proceeds will partly fund capped call transactions to limit stock dilution
- Axon also expanded its revolving credit facility from $300 million to $500 million
- AXON stock dropped roughly 10% on the news Tuesday
Axon Enterprise (AXON) dropped close to 10% on Tuesday after announcing plans to offer $1.0 billion in 0% interest-bearing convertible senior notes maturing in 2031. The stock was trading around $442 at the time of writing, down over $47 on the session.
The notes are senior unsecured obligations and will not carry regular interest. They mature on September 15, 2031, unless converted, redeemed, or repurchased before that date.
Axon also granted underwriters an option to purchase up to an additional $150 million in notes to cover excess demand, bringing the potential total offering to $1.15 billion.
Upon conversion, Axon can pay holders in cash, common stock, or a mix of both, at the company’s discretion. That flexibility is standard for this type of instrument but can leave investors uncertain about dilution risk.
To offset that risk, Axon plans to use part of the proceeds to fund capped call transactions. These are designed to reduce potential dilution of Axon’s common stock at the time of conversion.
The remaining proceeds are earmarked for general corporate purposes. That includes supporting growth and potentially acquiring or investing in new product lines, services, or technologies.
Credit Facility Expansion
Also on Tuesday, Axon entered into a second amendment to its existing credit agreement. The amendment expands its revolving credit facility from $300 million to $500 million, with the option to add a further $150 million on top of that.
The expanded facility carries interest at SOFR plus 1.25% to 1.75% and extends the maturity by up to five years from the amendment’s closing date. It is conditioned on the successful completion of the convertible notes offering.
The credit facility amendment adds leverage and interest coverage covenants. It is structured to give Axon more financial flexibility for growth and potential acquisitions going forward.
Wall Street Still Bullish
Despite Tuesday’s drop, the most recent analyst rating on AXON is a Buy, with a price target of $825. That implies significant upside from current levels even after the selloff.
Goldman Sachs, Morgan Stanley, JP Morgan, RBC Capital Markets, and Citigroup are acting as joint lead coordinators on the notes offering.
Starting September 20, 2029, Axon may redeem all or part of the notes for cash if its stock price hits at least 130% of the conversion price for at least 20 trading days within any 30 consecutive trading day period.
Axon’s market cap stood at approximately $38.94 billion before Tuesday’s decline. The company’s P/E ratio sits around 204, reflecting a high-growth valuation that leaves little room for surprises.
The convertible note offering was registered under the Securities Act of 1933 and is a public offering, meaning full SEC disclosure requirements apply.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
